Ledger.Open graph →

SEC Form D · Amendment · filed May 21, 2021

Cognos Therapeutics Inc

Offering

$14.3M

Sold

$3.8M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Inglewood, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Frank Adell · Inglewood, CAExec · Director Eli Gang · Inglewood, CADirector Richard Lerner · Inglewood, CADirector Winston Wu · Inglewood, CADirector Josh Shachar · Inglewood, CADirector Thomas Chen · Inglewood, CADirector Peter Mills · St. Peter Port, Y7Director Eugene S. Cotten · Houston, TXDirector T.J. Leverte · Sausalito, CADirector Peter Luber · Sausalito, CAExec · Director Michael Cowell · St. Peter Port, Y7Director Chris Mcerlane · St. Peter Port, Y7Director John M. Roberts · Morrisville, NCDirector Tyler Cauble · NASHVILLE, TNExec · Director Dovi Frances · BEVERLY HILLS, CADirector Steven B. Kimmelman · Independence, OHDirector David B. Conwill · Independence, OHDirector Meredith Gamble · HOUSTON, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗